English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduScientists at the UC Davis School of Medicine may have figured out why some people have trouble digesting sorbitol, a sugar alcohol used in sugar-free gum, mints, candy and other products.
Tag: Uc Davis
Type 2 Diabetes Alters the Behavior of Discs in the Vertebral Column
Type 2 diabetes alters the behavior of discs in the vertebral column, making them stiffer, and also causes the discs to change shape earlier than normal.
Gene therapy study identifies potential new treatment for liver cancer
Gene therapy with microRNA-22 produced better survival outcomes than the current FDA-approved drug for liver cancer and without noticeable toxicity in new mouse study.
High blood pressure in your 30s is associated with worse brain health in your 70s
New research from the UC Davis School of Medicine shows high blood pressure in early adulthood is associated with worse brain health in late life — especially for men. The results suggest that treating hypertension in young and middle-aged adults may help prevent dementia and Alzheimer’s disease.
A Tool to Prevent Deaths Due to Female Underrepresentation in Clinical Trials
ROCKVILLE, MD – Women are often underrepresented in cardiac clinical trials—yet they are at least at equally high risk of death due to cardiovascular disease, and at higher risk of developing drug-induced heart complications compared to men. Clinical trials of medicines generally rely on electrocardiograms (EKG) to measure a patient’s heart’s response to a medicine and determine its safety, yet males and females have a number of differences in their heart physiology that are reflected in consistent variations in their EKGs.
Could monoclonal antibodies replace opioids for chronic pain?
During the pandemic, physicians used infusions of monoclonal antibodies to help patients fight off COVID-19 infections. Now, in response to the U.S. opioid crisis, researchers at UC Davis are trying to create monoclonal antibodies that can help fight chronic pain. The research is funded with a $1.5 million grant from the National Institutes of Health’s HEAL Initiative, an aggressive effort to speed scientific solutions to stem the national’s opioid crisis.
PsychLight Sensor to Enable Discovery of New Psychiatric Drugs
UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.
NCCN Announces UC Davis Comprehensive Cancer Center as 31st Member Institution
NCCN announced that it has elected University of California (UC) Davis Comprehensive Cancer Center as its newest Member Institution joining 30 other leading academic cancer centers to improve and facilitate quality, effective, efficient, and accessible cancer care so patients can live better lives.
New four-year residential program for students with intellectual disabilities at the University of California, Davis
A new, residential four-year college program for students with intellectual disabilities is the first of its kind in the west and is expected to serve as a model for other California schools.
Researchers receive more than $53 million to study role of white matter lesions in dementia
A $53.6 million grant from the National Institutes of Health will aid brain scientists, including a researcher from The University of Texas Health Science Center at Houston (UTHealth), in studying the role of incidental white matter lesions, or WMLs, in dementia among diverse people with cognitive complaints.
UC Davis Health experts available for interviews in English and Spanish on contact tracing
UC Davis Health experts in public health and epidemiology are available to discuss the role and importance of contact tracing in infectious disease control. Dr. Garcia can do interviews in Spanish. Lorena Garcia is an associate professor of epidemiology in…
Impacting the Human Condition and the Planet
In our series, The ECS Community Adapts and Advances, Jerry Woodall shares insights from his long career working in industry and academia. An inventor and scientist, Jerry is best known for developing the first commercially-viable red LEDs used in automobile brake lights and traffic lights, CD/DVD players, TV remote controls, and computer networks. He received the US National Medal of Technology and Innovation for “his pioneering role in the research and development of compound semiconductor materials and devices.” Currently Distinguished Professor of Electrical and Computer Engineering at the University of California, Davis (UC Davis), Jerry served as ECS President from 1990-1991. ECS awarded Jerry the Electronics Division Award (1980), Solid State Science and Technology Award (1985), Edward Goodrich Acheson Award (1998), and named him a Fellow of The Electrochemical Society (1992).